Convergence’s management team and scientists will be attending the events below. If you would like to meet with a member of the team please contact us.                    

  Abstract Control number: 3129 -
A Novel Proof Of Concept, Placebo Controlled, Randomised Withdrawal Study, To Evaluate The Safety And Efficacy Of CNV1014802 In Patients With Trigeminal Neuralgia. 
S. Tate, J. Palmer, V. Morisset, G. Giblin, M. Obermann, D. Ettlin, G. Cruccu, K. Gunn, J. Zakrzewska.
Friday, October 10, 2014 9:30am - 10:30am: PF438

  Abstract Control number: 3068 -
Pharmacological Investigation Of The Nav1.7 Gain-Of-Function Mutations Involved In Rare Pain Genetic Disorders: A Path To Personalised Medicine? 
V. Morisset, D. Derjean, F. Rugiero, M. Durand, S. Dib-Hajj, S. Tate, S. Waxman.
Friday, October 10, 2014 9:30am - 10:30am: PF020